0

Patient Derived Xenograft Market by Application and Geography - Forecast and Analysis 2021-2025

  • Published: Oct 2021
  • Pages: 120
  • SKU: IRTNTR71179
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

The patient derived xenograft market share should rise by USD 188.19 million from 2021 to 2025 at a CAGR of 16.66%.

This patient derived xenograft market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by application (preclinical drug development and bio marker analysis) and geography (North America, Europe, Asia, and ROW). The patient derived xenograft market report also offers information on several market vendors, including Champions Oncology Inc., Charles River Laboratories International Inc., Experimental Pharmacology and Oncology EPO Berlin Buch GmbH, Hera Biolabs Inc., Oncodesign SA, PerkinElmer Inc., The Jackson Laboratory, UROSPHERE SAS, and WuXi AppTec Co. Ltd. among others.

What will the Patient Derived Xenograft Market Size be in 2021?

Patient Derived Xenograft Market Size

To Unlock the Patient Derived Xenograft Market Size for 2021 and Other Important Statistics, Download the Free Report Sample!

Patient Derived Xenograft Market: Key Drivers and Trends

The growing demand for personalized medicine is notably driving the patient derived xenograft market growth, although factors such as stringent government guidelines regarding the ethical use of animals in cancer research may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the patient derived xenograft industry. The holistic analysis of the drivers will help in predicting end goals and refining marketing strategies to gain a competitive edge.

This patient derived xenograft market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Patient Derived Xenograft Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Champions Oncology Inc.
  • Charles River Laboratories International Inc.
  • Experimental Pharmacology and Oncology EPO Berlin Buch GmbH
  • Hera Biolabs Inc.
  • Oncodesign SA
  • PerkinElmer Inc.
  • The Jackson Laboratory
  • UROSPHERE SAS
  • WuXi AppTec Co. Ltd.

 

The vendor landscape of the patient derived xenograft market entails successful business strategies deployed by the vendors. The patient derived xenograft market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the patient derived xenograft market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Patient Derived Xenograft Market?

Patient Derived Xenograft Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

40% of the market's growth will originate from North America during the forecast period. The US and Mexico are the key markets for patient derived xenograft market in North America. 

The report offers an up-to-date analysis of the geographical composition of the market. North America has been recording a significant growth rate and is expected to offer several growth opportunities to market vendors during the forecast period. The development of immunodeficient rats will facilitate the patient derived xenograft market growth in North America over the forecast period. The report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for vendors.

What are the Revenue-generating Application Segments in the Patient Derived Xenograft Market?

Patient Derived Xenograft Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The patient derived xenograft market share growth by the preclinical drug development segment has been significant. This report provides insights on the impact of the unprecedented outbreak of COVID-19 on market segments. Through these insights, you can safely deduce transformation patterns in consumer behavior, which is crucial to gauge segment-wise revenue growth during 2021-2025 and embrace technologies to improve business efficiency.

This report provides an accurate prediction of the contribution of all the segments to the growth of the patient derived xenograft market size. Furthermore, our analysts have indicated actionable market insights on post COVID-19 impact on each segment, which is crucial to predict change in consumer demand.

Patient Derived Xenograft Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 16.66%

Market growth 2021-2025

$ 188.19 million

Market structure

Fragmented

YoY growth (%)

12.13

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 40%

Key consumer countries

US, Canada, Mexico, Germany, UK, France, China, Japan, and India

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Companies profiled

Champions Oncology Inc., Charles River Laboratories International Inc., Experimental Pharmacology and Oncology EPO Berlin Buch GmbH, Hera Biolabs Inc., Oncodesign SA, PerkinElmer Inc., The Jackson Laboratory, UROSPHERE SAS, and WuXi AppTec Co. Ltd.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Factors Covered in this Patient Derived Xenograft Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive patient derived xenograft market growth during the next five years
  • Precise estimation of the patient derived xenograft market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the patient derived xenograft market across North America, Europe, Asia, and ROW 
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of patient derived xenograft market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025

    Five Forces Analysis

    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by Application

    • Market segments
    • Comparison by Application
    • Preclinical drug development - Market size and forecast 2020-2025
    • Bio marker analysis - Market size and forecast 2020-2025
    • Market opportunity by Application

    Customer landscape

    • Customer landscape

    Geographic Landscape

    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity by geography
    • Market drivers
    • Market challenges
    • Market trends

    Vendor Landscape

    • Overview
    • Landscape disruption

    Vendor Analysis

    • Vendors covered
    • Market positioning of vendors
    • Champions Oncology Inc.
    • Charles River Laboratories International Inc.
    • Experimental Pharmacology and Oncology EPO Berlin Buch GmbH
    • Hera Biolabs Inc.
    • Oncodesign SA
    • PerkinElmer Inc.
    • The Jackson Laboratory
    • UROSPHERE SAS
    • WuXi AppTec Co. Ltd.

    Appendix

    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

    Research Framework

    Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

    TechnavioINFORMATION SOURCES

    Primary sources

    • Manufacturers and suppliers
    • Channel partners
    • Industry experts
    • Strategic decision makers

    Secondary sources

    • Industry journals and periodicals
    • Government data
    • Financial reports of key industry players
    • Historical data
    • Press releases
    Technavio

    TechnavioDATA ANALYSIS

    Data Synthesis

    • Collation of data
    • Estimation of key figures
    • Analysis of derived insights

    Data Validation

    • Triangulation with data models
    • Reference against proprietary databases
    • Corroboration with industry experts
    Technavio

    TechnavioREPORT WRITING

    Qualitative

    • Market drivers
    • Market challenges
    • Market trends
    • Five forces analysis

    Quantitative

    • Market size and forecast
    • Market segmentation
    • Geographical insights
    • Competitive landscape
    Interested in this report?
    Get your sample now!
    Patient Derived Xenograft market growth will increase by $188.19 million during 2020-2025.
    The patient derived xenograft market is expected to grow at a CAGR of 16.66% during 2020-2025.
    Technavio has segmented the patient derived xenograft market by application (Preclinical drug development and Bio marker analysis) and geographic (North America, Europe, Asia, and ROW).
    Champions Oncology Inc., Charles River Laboratories International Inc., Experimental Pharmacology and Oncology EPO Berlin Buch GmbH, Hera Biolabs Inc., Oncodesign SA, PerkinElmer Inc., Pharmatest Services Oy , The Jackson Laboratory, UROSPHERE SAS, WuXi AppTec Co. Ltd. are a few of the key vendors in the patient derived xenograft market.
    North America will register the highest growth rate of 39.95% among the other regions. Therefore, the patient derived xenograft market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
    • US
    • Canada
    • Mexico
    • Germany
    • UK
    • France
    • China
    • Japan
    • India
    The key factors driving the patient derived xenograft market growth are:
    • Growing demand for personalized medicine
    The patient derived xenograft market vendors should focus on grabbing business opportunities from the preclinical drug development segment as it accounted for the largest market share in the base year.
    • What are the key global market and the regional market share?
    • What are the revenue-generating key market segments?
    • What are the key factors driving and challenging this market’s growth?
    • Who are the key market vendors and their growth strategies?
    • What are the latest trends influencing the growth of this market?
    • What are the variables influencing the market growth in the primary regions?
    • What are the factors influencing the growth of the parent market?
    • Off-the-shelf research reports
    • Reports can be tailored to meet the customer's needs
    • Trusted by more than 100 fortune 500 organizations
    • Information about the market's key drivers, trends, and challenges
    • Parent market analysis
    • Every week, 50,000 people visit our subscription platform
    • Detailed vendors report with competitive landscape
    • Covid-19 impact and recovery analysis
    • Data on revenue-generating market segments
    • Details on the market shares of various regions
    • Five-force market analysis

    Certified ISO 9001 : 2015

    We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

    We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

    Safe and Secure SSL Encrypted
    Technavio

    info
    close
    • Single User:

      Quick and easy buy and download option

    • Enterprise:

      Flexible option - Complimentary customization included

    2500 USD

    Technavio Get the report (PDF) sent to your email within minutes.

    Subscribe & Save

    Get lifetime access to our
    Technavio Insights

    Customized Report as per your Business Needs

    • Our analysts will work directly with you and understand your needs
    • Get data on specified regions or segments, competitor and Vendors
    • Data will be formatted and presented as per your requirements
    • We offer $1000 worth of FREE customization at the time of purchase

    Let us help you make report more suited to your requirements.

    • Get a competitive breakdown as per your niche industry
    • Customize the data with various metrics that meet your business prerequisite
    • Understand Revenue Sources, Customers and many more
    • Details on Market Share
    • These customizations are done in a short amount of time by our analysts and industry experts
    Technavio
    Enquire Before Buying
    17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>